DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Remicade (Infliximab) - News

 
 



News related to Remicade (Infliximab) and/or conditions it is approved for

Remicade Phase 3 data show long-term psoriasis response
Source: The Doctors Lounge - Dermatology
Findings from two Phase 3 studies show high-level, sustained response with maintenance therapy.

Hospira launches first biosimilar monoclonal antibody (mAb) Inflectra (infliximab) in the UK
Source: Arthritis / Rheumatology News From Medical News Today [2015.02.27]
Hospira, Inc., a world leader in the development of biosimilar therapies, recently announced the UK launch of the first biosimilar monoclonal antibody (mAb), Inflectra (infliximab).

Ulcerative Colitis: Markers Predict Outcomes With Infliximab
Source: Medscape Gastroenterology Headlines [2015.02.24]
A five-marker panel identifies those at highest risk for relapse and colectomy.
Medscape Medical News

Inflectra (infliximab) patient registry reports interim results in the treatment of inflammatory bowel disease
Source: Clinical Trials / Drug Trials News From Medical News Today [2015.02.23]
Data have been presented today on the use of Hospira's Inflectra (infliximab), the world's first approved biosimilar monoclonal antibody (mAb), at the European Crohn's and Colitis Organisation...

Hospira launches first biosimilar monoclonal antibody Inflectra (infliximab) in major European markets
Source: Arthritis / Rheumatology News From Medical News Today [2015.02.17]
Hospira, Inc., a world leader in the development of biosimilar therapies, has announced the launch of the first biosimilar monoclonal antibody (mAb), Inflectra (infliximab), in major European...

Celltrion launches world's first biosimilar monoclonal antibody Remsima in 12 new European markets
Source: Arthritis / Rheumatology News From Medical News Today [2015.02.26]
Celltrion Healthcare has announced the launch of Remsima (infliximab) in 12 European markets: Austria, Belgium, Denmark, France, Germany, Greece, Italy, Luxembourg, the Netherlands, Spain, Sweden...

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015